Haemonetics Corp. (HAE)
108.40
-0.40
(-0.37%)
USD |
NYSE |
Aug 24, 16:00
108.39
-0.01
(-0.01%)
After-Hours: 20:00
Haemonetics Enterprise Value : 5.880B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.880B |
| August 21, 2026 | 5.898B |
| August 20, 2026 | 5.872B |
| August 19, 2026 | 5.880B |
| August 18, 2026 | 5.709B |
| August 17, 2026 | 5.055B |
| August 14, 2026 | 5.080B |
| August 13, 2026 | 5.060B |
| August 12, 2026 | 5.104B |
| August 11, 2026 | 4.917B |
| August 10, 2026 | 4.889B |
| August 07, 2026 | 4.945B |
| August 06, 2026 | 4.817B |
| August 05, 2026 | 4.752B |
| August 04, 2026 | 4.833B |
| August 03, 2026 | 4.897B |
| July 31, 2026 | 4.840B |
| July 30, 2026 | 4.808B |
| July 29, 2026 | 4.835B |
| July 28, 2026 | 4.704B |
| July 27, 2026 | 4.584B |
| July 24, 2026 | 4.533B |
| July 23, 2026 | 4.470B |
| July 22, 2026 | 4.499B |
| July 21, 2026 | 4.501B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.505B |
| July 17, 2026 | 4.491B |
| July 16, 2026 | 4.520B |
| July 15, 2026 | 4.438B |
| July 14, 2026 | 4.334B |
| July 13, 2026 | 4.447B |
| July 10, 2026 | 4.415B |
| July 09, 2026 | 4.361B |
| July 08, 2026 | 4.307B |
| July 07, 2026 | 4.356B |
| July 06, 2026 | 4.362B |
| July 02, 2026 | 4.364B |
| July 01, 2026 | 4.354B |
| June 30, 2026 | 4.361B |
| June 29, 2026 | 4.429B |
| June 26, 2026 | 4.527B |
| June 25, 2026 | 4.542B |
| June 24, 2026 | 4.327B |
| June 23, 2026 | 4.323B |
| June 22, 2026 | 4.311B |
| June 18, 2026 | 4.386B |
| June 17, 2026 | 4.321B |
| June 16, 2026 | 4.397B |
| June 15, 2026 | 4.510B |
| June 12, 2026 | 4.568B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 83.12B |
| Integra LifeSciences Holdings Corp. | 3.073B |
| Globus Medical, Inc. | 10.80B |
| Abbott Laboratories | 229.54B |
| AngioDynamics, Inc. | 614.71M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 33.01M |
| Revenue (Quarterly) | 339.38M |
| Total Expenses (Quarterly) | 306.37M |
| EPS Diluted (Quarterly) | 0.7223 |
| Gross Profit Margin (Quarterly) | 56.98% |
| Profit Margin (Quarterly) | 9.73% |
| Earnings Yield | 1.89% |
| Operating Earnings Yield | 4.91% |
| Normalized Earnings Yield | 3.083 |